RU2449729C2 - Рентгеновская установка для формирования изображения исследуемого объекта и ее применение - Google Patents
Рентгеновская установка для формирования изображения исследуемого объекта и ее применение Download PDFInfo
- Publication number
- RU2449729C2 RU2449729C2 RU2007148223/14A RU2007148223A RU2449729C2 RU 2449729 C2 RU2449729 C2 RU 2449729C2 RU 2007148223/14 A RU2007148223/14 A RU 2007148223/14A RU 2007148223 A RU2007148223 A RU 2007148223A RU 2449729 C2 RU2449729 C2 RU 2449729C2
- Authority
- RU
- Russia
- Prior art keywords
- ray
- intensity
- ray radiation
- receiver
- values
- Prior art date
Links
- 238000009434 installation Methods 0.000 title claims abstract description 10
- 230000015572 biosynthetic process Effects 0.000 title abstract description 5
- 230000005855 radiation Effects 0.000 claims abstract description 136
- 229910052729 chemical element Inorganic materials 0.000 claims abstract description 35
- 238000010521 absorption reaction Methods 0.000 claims description 24
- 238000012360 testing method Methods 0.000 claims description 13
- -1 iodine, lanthanides Chemical class 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 9
- 238000012937 correction Methods 0.000 claims description 7
- 229910052747 lanthanoid Inorganic materials 0.000 claims description 7
- 229910052797 bismuth Inorganic materials 0.000 claims description 5
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 239000000126 substance Substances 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 5
- 231100000915 pathological change Toxicity 0.000 abstract description 5
- 230000036285 pathological change Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 26
- 229910052740 iodine Inorganic materials 0.000 description 22
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 21
- 239000011630 iodine Substances 0.000 description 21
- 238000005259 measurement Methods 0.000 description 20
- 229910052688 Gadolinium Inorganic materials 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 17
- 238000004876 x-ray fluorescence Methods 0.000 description 16
- 238000001228 spectrum Methods 0.000 description 13
- 238000002591 computed tomography Methods 0.000 description 12
- QWUZMTJBRUASOW-UHFFFAOYSA-N cadmium tellanylidenezinc Chemical compound [Zn].[Cd].[Te] QWUZMTJBRUASOW-UHFFFAOYSA-N 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- MARUHZGHZWCEQU-UHFFFAOYSA-N 5-phenyl-2h-tetrazole Chemical compound C1=CC=CC=C1C1=NNN=N1 MARUHZGHZWCEQU-UHFFFAOYSA-N 0.000 description 10
- DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 230000000875 corresponding effect Effects 0.000 description 9
- 230000037396 body weight Effects 0.000 description 8
- 239000004065 semiconductor Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- ZPDFIIGFYAHNSK-UHFFFAOYSA-K gadobutrol Chemical compound [Gd+3].OCC(O)C(CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 ZPDFIIGFYAHNSK-UHFFFAOYSA-K 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 238000000295 emission spectrum Methods 0.000 description 6
- 150000002602 lanthanoids Chemical class 0.000 description 6
- 238000006073 displacement reaction Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000002601 radiography Methods 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 4
- 239000003570 air Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 3
- 229910052769 Ytterbium Inorganic materials 0.000 description 3
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 3
- 229910021417 amorphous silicon Inorganic materials 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- HZHFFEYYPYZMNU-UHFFFAOYSA-K gadodiamide Chemical compound [Gd+3].CNC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)NC HZHFFEYYPYZMNU-UHFFFAOYSA-K 0.000 description 3
- 238000009607 mammography Methods 0.000 description 3
- 229910052750 molybdenum Inorganic materials 0.000 description 3
- 239000011733 molybdenum Substances 0.000 description 3
- 230000010412 perfusion Effects 0.000 description 3
- 229920000656 polylysine Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000002307 prostate Anatomy 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000003325 tomography Methods 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XUHXFSYUBXNTHU-UHFFFAOYSA-N Iotrolan Chemical compound IC=1C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C=1N(C)C(=O)CC(=O)N(C)C1=C(I)C(C(=O)NC(CO)C(O)CO)=C(I)C(C(=O)NC(CO)C(O)CO)=C1I XUHXFSYUBXNTHU-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 238000000333 X-ray scattering Methods 0.000 description 2
- 238000002083 X-ray spectrum Methods 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000002583 angiography Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- GFSTXYOTEVLASN-UHFFFAOYSA-K gadoteric acid Chemical compound [Gd+3].OC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 GFSTXYOTEVLASN-UHFFFAOYSA-K 0.000 description 2
- DPNNNPAKRZOSMO-UHFFFAOYSA-K gadoteridol Chemical compound [Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 DPNNNPAKRZOSMO-UHFFFAOYSA-K 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229960004647 iopamidol Drugs 0.000 description 2
- XQZXYNRDCRIARQ-LURJTMIESA-N iopamidol Chemical compound C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I XQZXYNRDCRIARQ-LURJTMIESA-N 0.000 description 2
- 229960000824 iopentol Drugs 0.000 description 2
- IUNJANQVIJDFTQ-UHFFFAOYSA-N iopentol Chemical compound COCC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I IUNJANQVIJDFTQ-UHFFFAOYSA-N 0.000 description 2
- 229960002603 iopromide Drugs 0.000 description 2
- 229960003182 iotrolan Drugs 0.000 description 2
- 229910052746 lanthanum Inorganic materials 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000002600 positron emission tomography Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 238000002603 single-photon emission computed tomography Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 230000005469 synchrotron radiation Effects 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- QBPPRVHXOZRESW-UHFFFAOYSA-N 1,4,7,10-tetraazacyclododecane Chemical compound C1CNCCNCCNCCN1 QBPPRVHXOZRESW-UHFFFAOYSA-N 0.000 description 1
- AQOXEJNYXXLRQQ-KRWDZBQOSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid Chemical compound CCOC1=CC=C(C[C@@H](CN(CCN(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 AQOXEJNYXXLRQQ-KRWDZBQOSA-N 0.000 description 1
- ABWHOEHSTSEVRD-UHFFFAOYSA-K 2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;dysprosium(3+) Chemical compound [Dy+3].CNC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)NC ABWHOEHSTSEVRD-UHFFFAOYSA-K 0.000 description 1
- RZESKRXOCXWCFX-UHFFFAOYSA-N 2-[bis[2-[carboxymethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetic acid Chemical compound CNC(=O)CN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC(=O)NC RZESKRXOCXWCFX-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 230000005461 Bremsstrahlung Effects 0.000 description 1
- 102100031168 CCN family member 2 Human genes 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 208000036829 Device dislocation Diseases 0.000 description 1
- 229910052692 Dysprosium Inorganic materials 0.000 description 1
- 229910052691 Erbium Inorganic materials 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- IQUHNCOJRJBMSU-UHFFFAOYSA-N H3HP-DO3A Chemical compound CC(O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 IQUHNCOJRJBMSU-UHFFFAOYSA-N 0.000 description 1
- 229910052689 Holmium Inorganic materials 0.000 description 1
- 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 1
- OIRFJRBSRORBCM-UHFFFAOYSA-N Iopanoic acid Chemical compound CCC(C(O)=O)CC1=C(I)C=C(I)C(N)=C1I OIRFJRBSRORBCM-UHFFFAOYSA-N 0.000 description 1
- UXIGWFXRQKWHHA-UHFFFAOYSA-N Iotalamic acid Chemical compound CNC(=O)C1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I UXIGWFXRQKWHHA-UHFFFAOYSA-N 0.000 description 1
- JXMIBUGMYLQZGO-UHFFFAOYSA-N Iotroxic acid Chemical compound OC(=O)C1=C(I)C=C(I)C(NC(=O)COCCOCCOCC(=O)NC=2C(=C(C(O)=O)C(I)=CC=2I)I)=C1I JXMIBUGMYLQZGO-UHFFFAOYSA-N 0.000 description 1
- 229910052765 Lutetium Inorganic materials 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229910052779 Neodymium Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229910052777 Praseodymium Inorganic materials 0.000 description 1
- 229910052772 Samarium Inorganic materials 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 description 1
- 229910052775 Thulium Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- MXZROTBGJUUXID-UHFFFAOYSA-I [Gd+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)C(C([O-])=O)COCC1=CC=CC=C1 Chemical compound [Gd+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC(=O)[O-])CCN(CC([O-])=O)C(C([O-])=O)COCC1=CC=CC=C1 MXZROTBGJUUXID-UHFFFAOYSA-I 0.000 description 1
- XHJUBHJVXNTEPS-UHFFFAOYSA-N [Tc].[Zn] Chemical compound [Tc].[Zn] XHJUBHJVXNTEPS-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000002585 cerebral angiography Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229910021419 crystalline silicon Inorganic materials 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229960005423 diatrizoate Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000004993 emission spectroscopy Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- OCDAWJYGVOLXGZ-VPVMAENOSA-K gadobenate dimeglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)C(C([O-])=O)COCC1=CC=CC=C1 OCDAWJYGVOLXGZ-VPVMAENOSA-K 0.000 description 1
- 229960005063 gadodiamide Drugs 0.000 description 1
- LGMLJQFQKXPRGA-VPVMAENOSA-K gadopentetate dimeglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O LGMLJQFQKXPRGA-VPVMAENOSA-K 0.000 description 1
- RYHQMKVRYNEBNJ-BMWGJIJESA-K gadoterate meglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 RYHQMKVRYNEBNJ-BMWGJIJESA-K 0.000 description 1
- 229960005451 gadoteridol Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 229960004359 iodixanol Drugs 0.000 description 1
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 description 1
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 1
- 229960001025 iohexol Drugs 0.000 description 1
- 229960002979 iopanoic acid Drugs 0.000 description 1
- 229960000929 iotalamic acid Drugs 0.000 description 1
- 229960000506 iotroxic acid Drugs 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 description 1
- 229960003194 meglumine Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 238000010603 microCT Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- XZNXVSDNACTASG-RZNNTOFGSA-M sodium;3,5-diacetamido-2,4,6-triiodobenzoate;3,5-diacetamido-2,4,6-triiodobenzoic acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol Chemical compound [Na+].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I XZNXVSDNACTASG-RZNNTOFGSA-M 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000011410 subtraction method Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-L thiosulfate(2-) Chemical compound [O-]S([S-])(=O)=O DHCDFWKWKRSZHF-UHFFFAOYSA-L 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/482—Diagnostic techniques involving multiple energy imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
- A61B6/4208—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
- A61B6/4233—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector using matrix detectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/504—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of blood vessels, e.g. by angiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/507—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for determination of haemodynamic parameters, e.g. perfusion CT
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
- A61B6/4064—Arrangements for generating radiation specially adapted for radiation diagnosis specially adapted for producing a particular type of beam
- A61B6/4092—Arrangements for generating radiation specially adapted for radiation diagnosis specially adapted for producing a particular type of beam for producing synchrotron radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/58—Testing, adjusting or calibrating thereof
- A61B6/582—Calibration
- A61B6/583—Calibration using calibration phantoms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- High Energy & Nuclear Physics (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Mathematical Physics (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Theoretical Computer Science (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Measurement Of Radiation (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Nuclear Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005026940A DE102005026940A1 (de) | 2005-06-06 | 2005-06-06 | Röntgenanordnung zur Bilddarstellung eines Untersuchungsobjektes und Verwendung der Röntgenanordnung |
| DE102005026940.0 | 2005-06-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2007148223A RU2007148223A (ru) | 2009-11-27 |
| RU2449729C2 true RU2449729C2 (ru) | 2012-05-10 |
Family
ID=36581952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007148223/14A RU2449729C2 (ru) | 2005-06-06 | 2006-04-20 | Рентгеновская установка для формирования изображения исследуемого объекта и ее применение |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1890604A1 (fr) |
| JP (1) | JP2008541963A (fr) |
| KR (1) | KR20080020616A (fr) |
| CN (2) | CN101203179B (fr) |
| AU (1) | AU2006254747A1 (fr) |
| BR (1) | BRPI0611181A2 (fr) |
| CA (1) | CA2610964A1 (fr) |
| DE (1) | DE102005026940A1 (fr) |
| IL (1) | IL187846A0 (fr) |
| MX (1) | MX2007015406A (fr) |
| RU (1) | RU2449729C2 (fr) |
| WO (1) | WO2006131175A1 (fr) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2597026C1 (ru) * | 2015-06-22 | 2016-09-10 | Российская Федерация, от имени которой выступает Государственная корпорация по атомной энергии "Росатом" (Госкорпорация "Росатом") | Способ регистрации радиографических изображений, сформированных с помощью ионизирующего излучения |
| RU2603613C1 (ru) * | 2013-03-15 | 2016-11-27 | Эмтензор Гмбх | Носимая/переносная установка электромагнитной томографии |
| US9675254B2 (en) | 2012-11-21 | 2017-06-13 | Emtensor Gmbh | Electromagnetic tomography solutions for scanning head |
| US9724010B2 (en) | 2010-07-08 | 2017-08-08 | Emtensor Gmbh | Systems and methods of 4D electromagnetic tomographic (EMT) differential (dynamic) fused imaging |
| US10492700B2 (en) | 2013-03-15 | 2019-12-03 | Emtensor Gmbh | Methods of assessing the normalcy of biological tissue |
| US10921361B2 (en) | 2015-10-16 | 2021-02-16 | Emtensor Gmbh | Electromagnetic interference pattern recognition tomography |
| US11253164B2 (en) | 2016-11-23 | 2022-02-22 | Emtensor Gmbh | Use of electromagnetic field for tomographic imaging of head |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102007018102B4 (de) | 2007-04-16 | 2009-09-03 | Bayer Schering Pharma Aktiengesellschaft | Einrichtung zur strahlentherapeutischen Behandlung von Gewebe mittels einer Röntgen-CT-Anlage oder einer diagnostischen oder Orthovolt-Röntgen-Anlage |
| DE102007024158B4 (de) * | 2007-05-24 | 2017-09-14 | Bayer Intellectual Property Gmbh | Auswahlverfahren für zwei Kontrastmittel zur Verwendung in einer Dual-Energy-CT-Untersuchung, Kontrastmittelkombination und Erzeugung von CT-Aufnahmen mit einer Kontrastmittelkombination mit unterschiedlichen Energiespektren |
| DE102007027460B4 (de) * | 2007-06-14 | 2017-03-23 | Siemens Healthcare Gmbh | Verfahren zur Durchführung einer bildgebenden Messung mit einem energieselektiven Röntgendetektor |
| KR101689867B1 (ko) | 2010-09-15 | 2016-12-27 | 삼성전자주식회사 | 영상을 처리하는 방법, 이를 수행하는 영상처리장치 및 의료영상시스템 |
| KR20140043317A (ko) | 2011-02-01 | 2014-04-09 | 덱셀라 리미티드 | 제한된 다이나믹 레인지의 전역 디지털 유방촬영(ffdm)을 이용한 큰 다이나믹 레인지의 유방조영술 |
| RU2465825C1 (ru) * | 2011-06-17 | 2012-11-10 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации | Способ диагностики опухолей мягких тканей |
| JP2013098168A (ja) * | 2011-10-28 | 2013-05-20 | Gamc Biotec Development Co Ltd | 透過型ｘ線管及び反射型ｘ線管 |
| WO2016079638A1 (fr) | 2014-11-20 | 2016-05-26 | Koninklijke Philips N.V. | Réducteur de flux de rayons x pour détecteur de comptage de photons |
| JP6803986B2 (ja) * | 2017-07-27 | 2020-12-23 | 富士フイルム株式会社 | 放射線画像撮影システム、ファントム、及び評価方法 |
| EP3877782A4 (fr) * | 2018-11-06 | 2022-05-18 | Shenzhen Xpectvision Technology Co., Ltd. | Procédés d'imagerie utilisant la fluorescence aux rayons x |
| IT201900006616A1 (it) * | 2019-05-07 | 2020-11-07 | Angiodroid S R L | Metodo per il miglioramento di immagini radiologiche nel corso di un'angiografia |
| DE102019213983A1 (de) * | 2019-09-13 | 2021-03-18 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Vorrichtung und verfahren zum bestimmen eines aufnahmeparameters und/oder zum bereitstellen einer wartungsempfehlung für eine computertomographieanlage |
| CN113759412B (zh) * | 2020-06-03 | 2023-08-22 | 上海联影医疗科技股份有限公司 | 获取束流形状和能量探测单元响应特征的方法、装置 |
| CN111915538B (zh) * | 2020-08-19 | 2024-03-19 | 南京普爱医疗设备股份有限公司 | 一种用于数字血管减影的图像增强方法及系统 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4887285A (en) * | 1986-03-18 | 1989-12-12 | U.S. Philips Corporation | Method and device for determining the spatial distribution of chemicals in an object |
| US6399951B1 (en) * | 2000-02-02 | 2002-06-04 | Ut-Battelle, Llc | Simultaneous CT and SPECT tomography using CZT detectors |
| RU2209644C2 (ru) * | 2000-07-05 | 2003-08-10 | Кумахов Мурадин Абубекирович | Рентгеновские средства для определения местоположения и лучевой терапии злокачественных новообразований |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8003354A (nl) * | 1980-06-09 | 1982-01-04 | Philips Nv | Stralingsonderzoekapparaat met beeldsubtractie. |
| EP1293229B1 (fr) * | 2001-04-16 | 2004-07-07 | Muradin Abubekirovich Kumakhov | Radioscopie utilisant le rayonnement k$g(a)- du gadolinium |
| EP1622649A2 (fr) * | 2003-05-06 | 2006-02-08 | Philips Intellectual Property & Standards GmbH | Appareil et procede pour examiner un objet au moyen de rayons x a dispersion elastique et d'un produit de contraste |
| DE10347961A1 (de) * | 2003-10-10 | 2005-06-09 | Schering Ag | Röntgenanordnung und Röntgenkontrastverfahren zur Bildgebung an einem mindestens ein röntgenkontrastgebendes Element enthaltenden Untersuchungsobjekt sowie Verwendung der Röntgenanordnung |
-
2005
- 2005-06-06 DE DE102005026940A patent/DE102005026940A1/de not_active Withdrawn
-
2006
- 2006-04-20 AU AU2006254747A patent/AU2006254747A1/en not_active Abandoned
- 2006-04-20 MX MX2007015406A patent/MX2007015406A/es active IP Right Grant
- 2006-04-20 WO PCT/EP2006/003908 patent/WO2006131175A1/fr active Application Filing
- 2006-04-20 CA CA002610964A patent/CA2610964A1/fr not_active Abandoned
- 2006-04-20 JP JP2008515068A patent/JP2008541963A/ja active Pending
- 2006-04-20 KR KR1020077028396A patent/KR20080020616A/ko not_active Application Discontinuation
- 2006-04-20 CN CN2006800198800A patent/CN101203179B/zh not_active Expired - Fee Related
- 2006-04-20 CN CN2011103515078A patent/CN102512188A/zh active Pending
- 2006-04-20 BR BRPI0611181-5A patent/BRPI0611181A2/pt not_active IP Right Cessation
- 2006-04-20 EP EP06724603A patent/EP1890604A1/fr not_active Withdrawn
- 2006-04-20 RU RU2007148223/14A patent/RU2449729C2/ru not_active IP Right Cessation
-
2007
- 2007-12-03 IL IL187846A patent/IL187846A0/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4887285A (en) * | 1986-03-18 | 1989-12-12 | U.S. Philips Corporation | Method and device for determining the spatial distribution of chemicals in an object |
| US6399951B1 (en) * | 2000-02-02 | 2002-06-04 | Ut-Battelle, Llc | Simultaneous CT and SPECT tomography using CZT detectors |
| RU2209644C2 (ru) * | 2000-07-05 | 2003-08-10 | Кумахов Мурадин Абубекирович | Рентгеновские средства для определения местоположения и лучевой терапии злокачественных новообразований |
Non-Patent Citations (1)
| Title |
|---|
| Peplow D.E. et al. "Measured Molecular Coherent Scattering Form Factors of Animal. Tissues, Plastics and Human Breast Tissue" Physics in Medicine and Biology, v.43, no.9, 1998, p.2431-2452. Batchelar D.L. et al. "Material-specific analysis using coherent-scatter imaging" Medical Physics, nv.29, no.8, 01.08.2002, p.1651-1660. * |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9724010B2 (en) | 2010-07-08 | 2017-08-08 | Emtensor Gmbh | Systems and methods of 4D electromagnetic tomographic (EMT) differential (dynamic) fused imaging |
| US10980421B2 (en) | 2012-11-21 | 2021-04-20 | Emtensor Gmbh | Electromagnetic tomography solutions for scanning head |
| US9675254B2 (en) | 2012-11-21 | 2017-06-13 | Emtensor Gmbh | Electromagnetic tomography solutions for scanning head |
| US11607134B2 (en) | 2012-11-21 | 2023-03-21 | Emtensor Gmbh | Emergency electromagnetic tomography solutions for scanning head |
| US9675255B2 (en) | 2012-11-21 | 2017-06-13 | Emtensor Gmbh | Electromagnetic tomography solutions for scanning head |
| US9924873B2 (en) | 2012-11-21 | 2018-03-27 | Emtensor Gmbh | Electromagnetic tomography solutions for scanning head |
| US10492700B2 (en) | 2013-03-15 | 2019-12-03 | Emtensor Gmbh | Methods of assessing the normalcy of biological tissue |
| RU2603613C1 (ru) * | 2013-03-15 | 2016-11-27 | Эмтензор Гмбх | Носимая/переносная установка электромагнитной томографии |
| US11517214B2 (en) | 2013-03-15 | 2022-12-06 | Emtensor Gmbh | Methods of identifying and locating tissue abnormalities in a biological tissue |
| US11806121B2 (en) | 2013-03-15 | 2023-11-07 | Emtensor Gmbh | Methods of identifying and locating tissue abnormalities in a biological tissue |
| US10980435B2 (en) | 2013-03-15 | 2021-04-20 | Emtensor Gmbh | Methods of identifying and locating tissue abnormalities in a biological tissue |
| RU2597026C1 (ru) * | 2015-06-22 | 2016-09-10 | Российская Федерация, от имени которой выступает Государственная корпорация по атомной энергии "Росатом" (Госкорпорация "Росатом") | Способ регистрации радиографических изображений, сформированных с помощью ионизирующего излучения |
| US10921361B2 (en) | 2015-10-16 | 2021-02-16 | Emtensor Gmbh | Electromagnetic interference pattern recognition tomography |
| US11892491B2 (en) | 2015-10-16 | 2024-02-06 | Emtensor Gmbh | Electromagnetic interference pattern recognition tomography |
| US11344216B2 (en) | 2016-11-23 | 2022-05-31 | Emtensor Gmbh | Use of electromagnetic field for tomographic imaging of head |
| US11350842B2 (en) | 2016-11-23 | 2022-06-07 | Emtensor Gmbh | Use of electromagnetic field for tomographic imaging of head |
| US11350841B2 (en) | 2016-11-23 | 2022-06-07 | Emtensorg Gmbh | Use of electromagnetic field for tomographic imaging of head |
| US11253164B2 (en) | 2016-11-23 | 2022-02-22 | Emtensor Gmbh | Use of electromagnetic field for tomographic imaging of head |
| US11883145B2 (en) | 2016-11-23 | 2024-01-30 | Emtensor Gmbh | Use of electromagnetic field for tomographic imaging of head |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006131175A1 (fr) | 2006-12-14 |
| IL187846A0 (en) | 2008-03-20 |
| BRPI0611181A2 (pt) | 2010-08-24 |
| CN101203179B (zh) | 2011-12-28 |
| CN102512188A (zh) | 2012-06-27 |
| DE102005026940A1 (de) | 2006-12-14 |
| KR20080020616A (ko) | 2008-03-05 |
| CA2610964A1 (fr) | 2006-12-14 |
| RU2007148223A (ru) | 2009-11-27 |
| MX2007015406A (es) | 2008-02-19 |
| JP2008541963A (ja) | 2008-11-27 |
| AU2006254747A1 (en) | 2006-12-14 |
| EP1890604A1 (fr) | 2008-02-27 |
| CN101203179A (zh) | 2008-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2449729C2 (ru) | Рентгеновская установка для формирования изображения исследуемого объекта и ее применение | |
| US20070025514A1 (en) | X-ray arrangement for graphic display of an object under examination and use of the x-ray arrangement | |
| Skarpathiotakis et al. | Development of contrast digital mammography | |
| Huda et al. | How do radiographic techniques affect image quality and patient doses in CT? | |
| US7672431B2 (en) | X-ray arrangement and x-ray contrast process for imaging an object under examination that contains at least one radiopaque element as well as use of the x-ray arrangement | |
| WO2007136952A2 (fr) | Imagerie aux rayons x avec faisceau conique à amélioration par contraste, évaluation, surveillance et administration de traitement | |
| Baldelli et al. | Evaluation of the minimum iodine concentration for contrast-enhanced subtraction mammography | |
| Wehrse et al. | Photon-counting detectors in computed tomography: from quantum physics to clinical practice. | |
| Fajardo et al. | Excretory urography using computed radiography. | |
| Jaffe | Medical Imaging: Many different techniques compete for attention, but each has unique strengths and applications | |
| JP2007508040A (ja) | Ｘ線不透過性要素を含む少なくとも１つの被検体での画像形成用のｘ線装置及びｘ線コントラスト方法並びにｘ線装置の使用 | |
| JP2007508040A5 (fr) | ||
| Reilly | X‐Ray, CT, and Mammography Technology | |
| Shuaib et al. | Examination Two: Questions | |
| Shuaib et al. | Examination Four: Questions | |
| Shuaib et al. | FRCR Physics MCQs in Clinical Radiology | |
| Scarfato et al. | The revolution of photon-counting CT towards new horizons of diagnostic imaging | |
| CL | Computed Tomography-Basics and its Applications in Dentistry. | |
| Azhari et al. | X-Ray Imaging and Computed Tomography | |
| Alghamdi | Radiologic image assessment using information loss theory by specially designed low contrast detail phantoms and extending it to CT | |
| Baldazzi et al. | Imaging characterization of an experimental Apparatus for Dual Energy Angiography | |
| SU950319A1 (ru) | Способ изготовлени фантома дл вы влени информативности рентгеновских методик | |
| Kabashi | Assessment of radiation doses to adult patients in computed tomography procedures | |
| Calliste | A new stationary digital breast tomosynthesis system: Implementation and characterization | |
| Hames et al. | James T. Dobbins III |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD4A | Correction of name of patent owner | ||
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20130421 |